24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publication dates

Leukemia Industry, November 2014 Market Reports from Top Publishers

You might be interested in: Flow Cytometry, Hematology, Therapeutics, more »


 
1-10 of about 100 reports for Leukemia

The Leukemia & Lymphoma Society, Inc. - Strategic SWOT Analysis Review

The Leukemia & Lymphoma Society, Inc. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Key elements such as swot analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs. The leukemia & lymphoma society, inc. - Strategic swot ...

EpiZyme, Inc. (EPZM) - Financial and Strategic SWOT Analysis Review

EpiZyme, Inc. (EPZM) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Modifying enzymes, and others. The company partners with celgene, glaxosmithkline, eisai, the leukemia & lymphoma society and multiple myeloma research foundation. Epizyme is headquartered in cambridge, massachusetts ...

Leukemia Drug Pathway Analyzer 2014

Leukemia Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • November 2014
  • by Bioseeker

... Before. Its capabilities moves you beyond powerful competitive intelligence to an opportunity seeking tool which lets you, by means of both present and emerging scientific knowledge, analyze the leukemia ...

 Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)-API Insights, 2014

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)-API Insights, 2014

  • $ 1 250
  • Industry report
  • November 2014
  • by Delve Insight

... Of the apis and intermediates being sourced from markets such as india and china.Delveinsight's, acute lymphocytic leukemia (all, acute lymphoblastic leukemia) -api insights, 2014 report describes ...

 Chronic Lymphocytic Leukemia (CLL)-API Insights, 2014

Chronic Lymphocytic Leukemia (CLL)-API Insights, 2014

  • $ 1 250
  • Industry report
  • November 2014
  • by Delve Insight

... Sourced from markets such as india and china.Delveinsight's, chronic lymphocytic leukemia (cll) -api insights, 2014 report describes the current therapeutics that are propelling the pharmaceutical ...

 Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)-API Insights, 2014

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)-API Insights, 2014

  • $ 1 250
  • Industry report
  • November 2014
  • by Delve Insight

... Of the apis and intermediates being sourced from markets such as india and china.Delveinsight's, chronic myelocytic leukemia (cml, chronic myeloid leukemia) -api insights, 2014 report describes ...

Leukemia Partnering 2009-2014

Leukemia Partnering 2009-2014

  • $ 995
  • Industry report
  • November 2014
  • by Currentpartnering

... Links to online copies of actual leukemia deals and contract documents as submitted to the securities exchange commission by companies and their partners, where available. Contract documents provide ...

Acute and Chronic Myelogenous Leukemia Partnering 2009-2014

Acute and Chronic Myelogenous Leukemia Partnering 2009-2014

  • $ 995
  • Industry report
  • November 2014
  • by Currentpartnering

... And chronic myelogenous leukemia partnering since 2009, including a summary of deals by industry sector, stage of development, deal type, and technology type. Numerous tables provide outline financial trends ...

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2014

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • October 2014
  • by Global Markets Direct

... Cell chronic lymphocytic leukemia- the report reviews key pipeline products under drug profile section which includes, product description, moa and r&d brief, licensing and collaboration details & other ...

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2014

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • October 2014
  • by Global Markets Direct

... Acute myelocytic leukemia (aml, acute myeloblastic leukemia) - pipeline by bergenbio as, h2 2014 92acute myelocytic leukemia (aml, acute myeloblastic leukemia) - pipeline by bio-path holdings ...

About 1 300 reports for Leukemia

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • Facts Spring 2014
  • April 2014
    28 pages
  • Cancer  

  • United States  

    North America  

View report >

14 Companies for Leukemia

Read our Company Profiles

Celgene Corp.

United States

GlaxoSmithKline P.L.C.

United States

Bristol-Myers Squibb Co.

United States

GlaxoSmithKline PLC

United Kingdom

Novartis Inc.

Switzerland

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.